miRNA-Based Therapeutics in the Era of Immune-Checkpoint Inhibitors
MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression by binding to complementary target regions on gene transcripts. Thus, miRNAs fine-tune gene expression profiles in a cell-type-specific manner and thereby regulate important cellular functions, such as cell growth, proliferat...
Main Authors: | Florian Huemer, Michael Leisch, Roland Geisberger, Nadja Zaborsky, Richard Greil |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/14/2/89 |
Similar Items
-
Identification of markers for predicting prognosis and endocrine metabolism in nasopharyngeal carcinoma by miRNA–mRNA network mining and machine learning
by: Xixia Zhang, et al.
Published: (2023-07-01) -
The Role of Immune-Related miRNAs in the Pathology of Kidney Transplantation
by: Emanuela Boštjančič, et al.
Published: (2021-08-01) -
Bilateral anterior uveitis after immunotherapy for malignant melanoma
by: Chia-Jui Chang, et al.
Published: (2018-01-01) -
Immune checkpoints and ncRNAs: pioneering immunotherapy approaches for hematological malignancies
by: Samira Anvari, et al.
Published: (2024-12-01) -
Paraneoplastic acral vascular syndrome in a patient with metastatic melanoma under immune checkpoint blockade
by: Thilo Gambichler, et al.
Published: (2017-05-01)